Medication Guide App

M R21 (Repaglinide 0.5 mg)

Pill imprint M R21 has been identified as Repaglinide 0.5 mg.

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M R21

Repaglinide 0.5 mg M R21
Repaglinide
Imprint:
M
R21
Strength:
0.5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Meglitinides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)